A detailed history of Janney Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Janney Capital Management LLC holds 450,664 shares of PFE stock, worth $12 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
450,664
Previous 451,610 0.21%
Holding current value
$12 Million
Previous $12.6 Million 3.21%
% of portfolio
0.88%
Previous 0.89%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $26,204 - $29,694
-946 Reduced 0.21%
450,664 $13 Million
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $624,225 - $731,475
-24,712 Reduced 5.19%
451,610 $12.6 Million
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $424,285 - $487,215
16,388 Added 3.56%
476,322 $13.2 Million
Q4 2023

Feb 07, 2024

BUY
$26.13 - $33.94 $1.18 Million - $1.53 Million
44,969 Added 10.84%
459,934 $13.2 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $163,466 - $191,075
5,094 Added 1.24%
414,965 $13.8 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $165,935 - $191,983
4,594 Added 1.13%
409,871 $15 Million
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $493,793 - $642,846
12,536 Added 3.19%
405,277 $16.5 Million
Q4 2022

Feb 01, 2023

BUY
$41.75 - $54.5 $443,552 - $579,008
10,624 Added 2.78%
392,741 $20.1 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $269,517 - $329,013
6,159 Added 1.64%
382,117 $16.7 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $13,865 - $16,440
298 Added 0.08%
375,958 $19.7 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $658,342 - $815,769
14,390 Added 3.98%
375,660 $19.4 Million
Q4 2021

Jan 27, 2022

SELL
$41.32 - $61.25 $161,891 - $239,977
-3,918 Reduced 1.07%
361,270 $21.3 Million
Q3 2021

Nov 01, 2021

SELL
$39.25 - $50.42 $238,326 - $306,150
-6,072 Reduced 1.64%
365,188 $15.7 Million
Q2 2021

Jul 26, 2021

SELL
$35.91 - $40.68 $92,468 - $104,751
-2,575 Reduced 0.69%
371,260 $14.5 Million
Q1 2021

Apr 27, 2021

SELL
$33.49 - $37.77 $251,241 - $283,350
-7,502 Reduced 1.97%
373,835 $13.5 Million
Q4 2020

Jan 25, 2021

SELL
$33.47 - $42.56 $671,910 - $854,392
-20,075 Reduced 5.0%
381,337 $14 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $1.46 Million - $1.71 Million
-45,938 Reduced 10.27%
401,412 $14.7 Million
Q2 2020

Jul 23, 2020

SELL
$30.12 - $36.54 $549,238 - $666,306
-18,235 Reduced 3.92%
447,350 $14.6 Million
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $1.5 Million - $2.15 Million
-55,642 Reduced 10.68%
465,585 $15.2 Million
Q4 2019

Jan 21, 2020

SELL
$32.92 - $37.36 $1.07 Million - $1.21 Million
-32,385 Reduced 5.85%
521,227 $20.4 Million
Q3 2019

Oct 28, 2019

SELL
$32.49 - $42.13 $633,262 - $821,155
-19,491 Reduced 3.4%
553,612 $19.9 Million
Q2 2019

Jul 29, 2019

SELL
$36.98 - $41.52 $698,256 - $783,980
-18,882 Reduced 3.19%
573,103 $24.8 Million
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $556,687 - $611,614
-14,845 Reduced 2.45%
591,985 $25.1 Million
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $449,829 - $512,854
-11,693 Reduced 1.89%
606,830 $26.5 Million
Q3 2018

Jan 04, 2019

SELL
$34.47 - $41.81 $48.2 Million - $58.4 Million
-1,397,031 Reduced 69.31%
618,523 $27.3 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $47.6 Million - $57.8 Million
1,381,303 Added 217.78%
2,015,554 $0
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $200,089 - $213,315
-6,067 Reduced 0.95%
634,251 $23 Million
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $281,127 - $326,146
-8,810 Reduced 1.36%
640,318 $22.7 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $246,157 - $261,181
-7,401 Reduced 1.13%
649,128 $23.5 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $20.4 Million - $22.4 Million
656,529
656,529 $23.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Janney Capital Management LLC Portfolio

Follow Janney Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Capital Management LLC with notifications on news.